MHRA

News

A report has concluded that the current regulatory framework in the UK is inadequate for healthcare AI, and makes 44 recommendations to set it right.

News

The MHRA has teamed up with a Manchester NHS trust to set up a regional innovation 'sandbox' to test new technologies like AI in clinical settings.

News

Eli Lilly has announced that orforglipron (Foundayo) is now available to be prescribed for eligible adults via private prescription.

News

The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.

News

Eli Lilly's oral GLP-1 agonist Foundayo has been approved for weight management and type 2 diabetes in the UK, its first European market.

News

Cytokinetics gets simultaneous MHRA and NICE approvals for hypertrophic cardiomyopathy (HCM) therapy Myqorzo.